Cargando…
P392 Comparative evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal infections
POSTER SESSION 3, SEPTEMBER 23, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Serum 1,3 β-D-glucan (BDG) has shown wide utility as a broad fungal biomarker for invasive fungal disease (IFD). Fungitell assay (USA) is the only FDA-approved kit available for the detection of BDG. We planned to compare the pe...
Autores principales: | Singh, Shreya, Agnihotri, Sourav, Kaur, Harsimran, Kanaujia, Rimjhim, Ghosh, Anup, Rudramurthy, Shivaprakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516059/ http://dx.doi.org/10.1093/mmy/myac072.P392 |
Ejemplares similares
-
The Comparative Evaluation of the Fujifilm Wako β-Glucan Assay and Fungitell Assay for Diagnosing Invasive Fungal Disease
por: Singh, Shreya, et al.
Publicado: (2022) -
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases
por: De Carolis, Elena, et al.
Publicado: (2020) -
P395 Clinical utility of semi-nested conventional PCR for diagnosis of mucormycosis in fresh clinical samples
por: Choudhary, Hansraj, et al.
Publicado: (2022) -
P205 Uncommon Aspergillus species encountered in human infections
por: Gupta, Prakriti, et al.
Publicado: (2022) -
Rhizopus homothallicus: An emerging pathogen in era of COVID-19 associated mucormycosis
por: Kaur, Harsimran, et al.
Publicado: (2021)